Vignesh Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.50 M
as on 24-10-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.51 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.21 Cr
as on 24-10-2024
- Revenue -26.15%
(FY 2023)
- Profit -96.73%
(FY 2023)
- Ebitda -79.36%
(FY 2023)
- Net Worth 1.31%
(FY 2023)
- Total Assets -2.16%
(FY 2023)
About Vignesh Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹14.51 Cr. The company has closed loans amounting to ₹1.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramaprabhu Ayyalasomayajula and Venkata Ayyalasomayajula serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC049093
- Company No.
049093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vignesh Life Sciences Pvt Ltd offer?
Vignesh Life Sciences Pvt Ltd offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Cough Syrup, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Ayurvedic Medicine, Herbal Products, Pharmaceutical Medicine, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Vignesh Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramaprabhu Ayyalasomayajula  | Director | 10-Feb-2006 | Current |
| Venkata Ayyalasomayajula | Director | 10-Feb-2006 | Current |
Financial Performance of Vignesh Life Sciences.
Vignesh Life Sciences Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.15% decrease. The company also saw a substantial fall in profitability, with a 96.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vignesh Life Sciences?
In 2023, Vignesh Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Mar 2024 | ₹13.00 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Nov 2022 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 02 Sep 2022 | ₹1.31 Cr | Open |
How Many Employees Work at Vignesh Life Sciences?
Vignesh Life Sciences has a workforce of 27 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vignesh Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vignesh Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
